{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:02:17Z","timestamp":1783191737808,"version":"3.54.6"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>A 55-year-old female patient exhibited erythematous nodular plaques on the right side of her face for more than 1 year. The dermatological examination identified mildly infiltrated erythematous patches, papules, and nodules varying in size from a wide bean to a coin on the right side of her face and nasal alae. Several nodules exhibited a yellow hue and coalesced, while the erythema presented a mildly annular configuration. The patient was diagnosed with sinus histiocytosis (Rosai-Dorfman disease) based on dermoscopy, reflectance confocal microscopy, and histopathological examination. The patient had previously had treatment at another hospital with thalidomide, methotrexate, hydroxychloroquine, and localized betamethasone injections, yielding disappointing outcomes. Subsequently, they pursued medical care at our hospital. Due to the inadequate response to the initial immunosuppressant treatment (thalidomide and methotrexate) over 2 weeks, fire needling was incorporated for an additional 2 weeks, leading to a modest improvement in the skin lesions. These treatments were then discontinued and replaced with oral tofacitinib monotherapy (5 mg twice daily), which resulted in marked regression of the skin lesions. Over a 4-month follow-up period, the skin lesions demonstrated significant flattening and fading, with no notable adverse effects observed. This case is the first report of the JAK inhibitor tofacitinib in the treatment of cutaneous Rosai-Dorfman disease, in conjunction with local fire needling intervention, providing a novel integrated therapeutic strategy combining traditional Chinese and Western medicine for refractory cases.<\/jats:p>","DOI":"10.3389\/fmed.2026.1771685","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:11:44Z","timestamp":1775707904000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tofacitinib combined with fire needle therapy for refractory cutaneous Rosai-Dorfman disease: a first case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuwen","family":"Zhang","sequence":"first","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Wuhan Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated to Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wuhan First Hospital, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Department of Dermatology, Wuhan First Hospital, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders.","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e239244","DOI":"10.1136\/bcr-2020-239244","article-title":"Cutaneous Rosai-Dorfman disease: a challenging diagnosis.","volume":"14","author":"Sampaio","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s13555-021-00557-1","article-title":"Cutaneous Rosai-Dorfman disease: a treatment challenge.","volume":"11","author":"Gawdzik","year":"2021","journal-title":"Dermatol Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(21)01812-2","article-title":"IgG4-related disease and Rosai-Dorfman-Destombes disease.","volume":"398","author":"Chen","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3324\/haematol.2019.219626","article-title":"Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.","volume":"105","author":"Goyal","year":"2020","journal-title":"Haematologica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","article-title":"JAK-STAT signaling maintains homeostasis in T cells and macrophages.","volume":"25","author":"Fortelny","year":"2024","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41586-024-08061-0","article-title":"Spatial proteomics identifies JAKi as treatment for a lethal skin disease.","volume":"635","author":"Nordmann","year":"2024","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis.","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"104215","DOI":"10.1016\/j.pdpdt.2024.104215","article-title":"Fire needle pretreatment with 5-aminolevulinic acid photodynamic therapy combined with low-dose isotretinoin in the treatment of severe refractory nodulocystic acne.","volume":"47","author":"Du","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"103836","DOI":"10.1016\/j.pdpdt.2023.103836","article-title":"Fire needle combined with photodynamic therapy for cutaneous infectious granulomatosis caused by mycobacterium chelonae: a case report.","volume":"45","author":"Tang","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1001\/jamaoncol.2022.4432","article-title":"Outcomes after treatment with cobimetinib in patients with rosai-dorfman disease based on KRAS and MEK Alteration Status.","volume":"8","author":"Abeykoon","year":"2022","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","article-title":"Rosai-Dorfman disease: an overview.","volume":"73","author":"Bruce-Brand","year":"2020","journal-title":"J Clin Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/imj.70108","article-title":"Successful treatment of Rosai-Dorfman disease in the era of targeted therapy.","volume":"55","author":"Ngo","year":"2025","journal-title":"Intern Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00403-024-02982-6","article-title":"Cutaneous Rosai-Dorfman disease: a systematic review and reappraisal of its treatment and prognosis.","volume":"316","author":"Dhrif","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.abd.2024.05.002","article-title":"Facial cutaneous Rosai-Dorfman disease treated with pulsed dye laser: a case report and literature review.","volume":"100","author":"Wang","year":"2025","journal-title":"An Bras Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms.","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamadermatol.2023.4090","article-title":"Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis.","volume":"160","author":"Ingrassia","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2302394","DOI":"10.1080\/09546634.2024.2302394","article-title":"Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review.","volume":"35","author":"Su","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103168","DOI":"10.1016\/j.autrev.2022.103168","article-title":"JAK inhibitors and systemic sclerosis: a systematic review of the literature.","volume":"21","author":"Moriana","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.pdpdt.2020.102103","article-title":"Photodynamic therapy pre-treated by fire needle combined with isotretinoin in the treatment of refractory perifolliculitis capitis abscedens et suffodiens: case report.","volume":"33","author":"Su","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"813748","DOI":"10.3389\/fimmu.2021.813748","article-title":"Anti-inflammatory effects of acupuncture at ST36 point: a literature review in animal studies.","volume":"12","author":"Oh","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1771685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:11:50Z","timestamp":1775707910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1771685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":23,"alternative-id":["10.3389\/fmed.2026.1771685"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1771685","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"article-number":"1771685"}}